drugset / Trial / NCT00301665

Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis

NCT00301665 ↗

Phase 2 Completed 138 enrolled Ipsen
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to evaluate the efficacy of botulinum toxin type A (Dysport®) injections into pericranial muscles compared to placebo to prevent migraine attacks.

Timeline

Start
2003-02
Primary completion
—
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic — Intramuscular

Indications